MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Visual system abnormalities and visual hallucinations in Parkinson’s disease

    M. Diez-Cirarda, A. Cabrera, A. Murueta-Goyena, A. Strafella, R. Del Pino, MA. Acera, O. Lucas-Jiménez, N. Ibarretxe-Bilbao, B. Tijero, JC. Gomez-Esteban, I. Gabilondo (Barakaldo, Spain)

    Objective: We aimed to identify clinical and imaging biomarkers of visual system injury associated with the presence of Visual hallucinations (VH) in Parkinson's disease (PD).…
  • 2022 International Congress

    Priorities of PD patients for treatment of cognitive-driven ADL impairment

    I. Liepelt-Scarfone, M. Bentele, S. Becker, C. Altmann, E. Schaeffer, K. Michaelis, S. Solbrig, K. Brockmann (Tübingen, Germany)

    Objective: To define cognitive-driven impairments in activities of daily living (ADL) with high priority for rehabilitation ranked by Parkinson’s disease (PD) patients. Background: Impairments in…
  • 2022 International Congress

    Blood-derived α-synuclein from Parkinson´s disease patients is able to seed pathology

    A. Kluge, J. Bunk, E. Schäffer, H. Knacke, A. Drobny, W. Xiang, R. Lucius, P. Arnold, F. Zunke, D. Berg (Kiel, Germany)

    Objective: To identify seeding capacities of soluble α-synuclein (α-syn) conformers derived from neuronal extracellular vesicles (NEs) from Parkinson´s disease (PD) patients. Background: PD pathology is…
  • 2022 International Congress

    Developing New Insights Into Clinical and Genetic Features of PD – The Global Parkinson’s Genetics Program (GP2) Clinical Cohorts Working Group

    M. Richer, C. Towns, A. Martinez-Carrasco, J. Solle, A. Singleton, C. Blauwendraat, M. Tan, H. Iwaki, D. Vitale, Y. Song, M. Nalls, T. Antar, H. Morris (London, United Kingdom)

    Objective: We aim to recruit Parkinson’s cohorts across the world for the Global Parkinson’s Genetics Program (GP2, http://gp2.org/), harmonize clinical data for joint analysis and…
  • 2022 International Congress

    Effect of wearing knee braces on unsteadiness on standing in a case with primary orthostatic tremor

    J. Tashiro, H. Ohtsuka, H. Fukaura, M. Hirotani, Y. Iida, T. Takahashi, S. Hamada, M. Nonaka, S. Honma, A. Takei, F. Moriwaka, K. Tashiro (Sapporo, Japan)

    Objective: To clarify the effect of wearing knee braces (KB) on unsteadiness on standing in a case with primary orthostatic tremor (OT) using stabilometry and…
  • 2022 International Congress

    Neurophysiological and Clinical Effects of Low-intensity Transcranial Ultrasound of the Motor Cortex in Parkinson’s Disease

    T. Grippe, Y. Shamli Oghli, G. Darmani, T. Arora, C. Sarica, C. Rinchon, J. Nankoo, C. Gunraj, R. Chen (Toronto, Canada)

    Objective: Evaluate the neurophysiological and clinical effects of transcranial ultrasound stimulation (TUS) of motor cortex (M1) in PD patients. Background: Low-intensity TUS is a novel,…
  • 2022 International Congress

    Cognitive profiles at presentation and subsequent cognitive decline in PD-MCI.

    S. Mirza, S. Duff-Canning, M. Masellis, C. Marras (Toronto, Canada)

    Objective: To determine cognitive profiles in a Parkinson‘s Disease-Mild Cognitive Impairment (PD-MCI) cohort, and study the relationship between baseline cognitive phenotype and subsequent cognitive decline.…
  • 2022 International Congress

    Qualification of Digital Endpoints of Function in Healthy Volunteers for Use in a Decentralized Natural History Study in Genetic Parkinson’s Disease (PD)

    S. Sankaranarayanan, C. Tomkins-Lane, D. Singamsetty, G. Yahalom, N. France, M. Maurer, C. Barlow (South San Francisco, USA)

    Objective: Our goal was to qualify digital and wearable devices to assess the Timed Up and Go (TUG) test and gait related parameters in healthy…
  • 2022 International Congress

    Correlation of Voice parameters and Dysphagia Severity in Multiple System Atrophy

    T. Hähnel, L. Berger, K. Schimming, A. Vogel, G. Ebersbach, B. Falkenburger, F. Gandor (Dresden, Germany)

    Objective: To investigate the correlation between speech parameters and dysphagia severity in patients with MSA. Background: Dysphagia is an early and underestimated symptom in MSA…
  • 2022 International Congress

    Explorative study of analysis of the role of NFL and IGF1 in Indian patients with PSP and its clinical correlation.

    R. Yelamanchi, S. Dey, R. Yadav, P. Pal, M. Debnath, V. Holla, N. Kamble, S. T N, T. Mullapudi (Bangalore, India)

    Objective: In this prospective cross sectional case control study, we have investigated the relationship of serum levels of Neurofilament light chain and Insulin like growth…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley